We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis (M22)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01803867
First Posted: March 4, 2013
Last Update Posted: February 27, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
PRA Health Sciences
Information provided by (Responsible Party):
Acorda Therapeutics
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)